Laparoscopic Sleeve Gastrectomy Gains in Prominence
Bariatric surgery is a top weight loss approach. Not
only is bariatric surgery viewed as a top weight
loss method, bariatric surgery appears to be a good
way to resolve type 2 diabetes in many patients.
Therefore, bariatric surgery continues to gain
prominence. The three leading forms of bariatric
surgery are laparoscopic gastric bypass surgery,
laparoscopic sleeve gastrectomy (LSG), and
laparoscopic adjustable gastric band (LAGB). And
laparoscopic sleeve gastrectomy is gaining in
popularity in many quarters of the world.
For example, LAGB is used less and less in New Zealand. This lessening of usage prompted investigators to launch a comparison study to look at some different bariatric surgery results from a single surgeon's practice. The study consisted of 228 patients, where approximately 41% of the patients had undergone LAGB and about 58% of the patients had undergone LSG. The study concluded that LAGB produced "a significantly reduced level of weight loss but higher complications than LSG."
In another study, LSG was evaluated for effectiveness in patients with a BMI between 30 and 35. In the study, 192 patients were divided into two groups. Patients with BMI's between 30 and 35, approximately 26% of the patients, comprised one group, and patients with a BMI greater than 35, approximately 75% of the 192 patients, comprised the other group. The study's investigators concluded that "LSG achieved excellent outcomes without severe complications for mildly obese patients." Further the investigators concluded that "LSG could serve as a safe and effective stand-alone procedure to achieve sustained weight loss and comorbidity resolution in patients with a lower BMI.
The two above-mentioned studies can be beneficial to bariatric surgeons and non-surgical obesity medicine specialists. These studies show why many believe that laparoscopic sleeve gastrectomy is safe and effective. And these types of studies can enable both bariatric surgeons and non-surgical obesity medicine specialists to have more confidence in the LSG weight loss approach.
For example, LAGB is used less and less in New Zealand. This lessening of usage prompted investigators to launch a comparison study to look at some different bariatric surgery results from a single surgeon's practice. The study consisted of 228 patients, where approximately 41% of the patients had undergone LAGB and about 58% of the patients had undergone LSG. The study concluded that LAGB produced "a significantly reduced level of weight loss but higher complications than LSG."
In another study, LSG was evaluated for effectiveness in patients with a BMI between 30 and 35. In the study, 192 patients were divided into two groups. Patients with BMI's between 30 and 35, approximately 26% of the patients, comprised one group, and patients with a BMI greater than 35, approximately 75% of the 192 patients, comprised the other group. The study's investigators concluded that "LSG achieved excellent outcomes without severe complications for mildly obese patients." Further the investigators concluded that "LSG could serve as a safe and effective stand-alone procedure to achieve sustained weight loss and comorbidity resolution in patients with a lower BMI.
The two above-mentioned studies can be beneficial to bariatric surgeons and non-surgical obesity medicine specialists. These studies show why many believe that laparoscopic sleeve gastrectomy is safe and effective. And these types of studies can enable both bariatric surgeons and non-surgical obesity medicine specialists to have more confidence in the LSG weight loss approach.
-------------------------------------------------------
Tags: , ,
Tags: , ,
Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home